Pfizer beats EPS estimates for the 12th quarter. Explore PFE's oncology success, cost-cutting impact, and why it's rated a ...

Two preventive tools — a maternal vaccine and a monoclonal antibody — were tied to a recent drop in RSV hospitalization rates for U.S. babies.

Pfizer's maternal vaccine, sold as Abrysvo, and Sanofi and AstraZeneca's antibody shot, Beyfortus, are available in the ...

An aide to U.S. Health Secretary Robert F. Kennedy Jr. is seeking more information about three vaccines recommended by a ...

CDC's RSV vaccine recommendations from Pfizer and GSK face review by HHS advisor William "Reyn" Archer III. Read more here.

RSV virus in babies, children and adults – symptoms and warning signs A single-shot therapy offered to newborns in Ireland between September last and the end of February has dramatically reduced ...

Kennedy Jr., who oversees the FDA, intends to set new regulatory standards vaccine manufacturers couldn’t possibly meet. The shift could immediately affect access to Covid boosters, and adds ...

The Trump administration‘s effort to impose new requirements on Novavax’s COVID-19 vaccine — the nation ... mRNA vaccines made by Pfizer and Moderna, have earned full FDA approval for ...

Pfizer's CEO said tariff uncertainty is hindering the company from making big investments in the US. Albery Bourla said there could be "tremendous investments" in R&D and manufacturing in the US ...

Pfizer in the past showed its prowess here by partnering with BioNTech to develop and commercialize what ended up becoming the world's top-selling coronavirus vaccine. Of course, all of that is ...

The drug, which will be rolled out in a prefilled injection in the second quarter of the current fiscal year in India, is used for the prevention of respiratory syncytial virus (RSV), which is a ...

On the flip side, COVID vaccine Comirnaty is doing better than its antiviral counterpart, delivering a 62% revenue boost versus the first quarter of 2024. Outside of Pfizer's COVID products ...